Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
Top Cited Papers
- 1 April 2016
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (3) , 655-664
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapyBiomaterials, 2014
- Routes and mechanisms of extracellular vesicle uptakeJournal of Extracellular Vesicles, 2014
- P-glycoprotein Mediates Drug Resistance via a Novel Mechanism Involving Lysosomal SequestrationJournal of Biological Chemistry, 2013
- Exosomes: Mediators of Neurodegeneration, Neuroprotection and TherapeuticsMolecular Neurobiology, 2013
- Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytesNucleic Acids Research, 2012
- Microvesicle-associated AAV Vector as a Novel Gene Delivery SystemMolecular Therapy, 2012
- Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current ProgressNanomedicine, 2010
- Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological FluidsCurrent Protocols in Cell Biology, 2006
- Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial CellsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Fundamental Relationships Between the Composition of Pluronic Block Copolymers and Their Hypersensitization Effect in MDR Cancer CellsPharmaceutical Research, 1999